Abstract
Sialylation at the non-reducing end of glycoconjugates is an important biological process in cellular recognitions, tumor metastases, and immune responses, which are mediated by a family of enzymes known as sialyltransferases. Inhibition of sialyltransferases may prove useful in elucidating the biological functions of sialylation and may have therapeutic applications. This review summarizes the recent development in this field with particular focus on the strategies used for the design of carbohydrate mimetics and the structure-activity relationships of substrate-based sialyltransferase inhibitors.
Original language | English (US) |
---|---|
Pages (from-to) | 32-47 |
Number of pages | 16 |
Journal | Medicinal Research Reviews |
Volume | 23 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2003 |
Externally published | Yes |
Keywords
- Carbohydrate mimetics
- Inhibitor
- Review
- Sialyltransferase
- Structure-activity relationship
ASJC Scopus subject areas
- Molecular Medicine
- Pharmacology
- Drug Discovery